Ethyl 5-chloro-2-sulfanylbenzoate;tetrakis(triphenylphosphane)
C81H69ClO2P4S — CID 158137051
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethyl 5-chloro-2-sulfanylbenzoate;tetrakis(triphenylphosphane)
Ethyl 5-chloro-2-sulfanylbenzoate;tetrakis(triphenylphosphane) (PubChem CID 158137051) has the molecular formula C81H69ClO2P4S and a molecular weight of 1265.86 g/mol. Its IUPAC name is ethyl 5-chloro-2-sulfanylbenzoate;tetrakis(triphenylphosphane).
Molecular Properties
| Compound Name | Ethyl 5-chloro-2-sulfanylbenzoate;tetrakis(triphenylphosphane) |
|---|---|
| PubChem CID | 158137051 |
| Molecular Formula | C81H69ClO2P4S |
| Molecular Weight | 1265.86 g/mol |
| Exact Mass | 1264.37 |
| IUPAC Name | ethyl 5-chloro-2-sulfanylbenzoate;tetrakis(triphenylphosphane) |
| SMILES | CCOC(=O)c1cc(Cl)ccc1S.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1 |
| InChI | InChI=1S/4C18H15P.C9H9ClO2S/c4*1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18;1-2-12-9(11)7-5-6(10)3-4-8(7)13/h4*1-15H;3-5,13H,2H2,1H3 |
| InChIKey | FTLWITIBJWCCKG-UHFFFAOYSA-N |
| XLogP | 16.58 |
| TPSA | 26.30 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 89 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1265.86 |
| LogP ≤ 5 | 16.58 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'phosphor', 'substructure': 'N/A'}, {'alert_name': 'thiol_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158137051 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.